REGULATED PRESS RELEASE published on 09/09/2024 at 17:35, 1 year 2 months ago Disclosure of transactions in own shares on September 2 to September 6, 2024
BRIEF published on 09/05/2024 at 08:05, 1 year 3 months ago EURAZEO Becomes New Shareholder in Moria Alongside Naxicap Partners EURAZEO Investment Moria Naxicap Partners Ophthalmic Surgery
REGULATED PRESS RELEASE published on 09/05/2024 at 08:00, 1 year 3 months ago EURAZEO, NEW SHAREHOLDER IN MORIA ALONGSIDE ITS HISTORIC SPONSOR NAXICAP PARTNERS Eurazeo becomes a shareholder in Moria, a top ophthalmic surgery leader, alongside Naxicap Partners. Moria plans to expand its expertise globally and enhance innovation Innovation EURAZEO Moria Naxicap Partners Ophthalmic Surgery
REGULATED PRESS RELEASE published on 09/02/2024 at 17:35, 1 year 3 months ago Disclosure of transactions in own shares on August 26 to August 30, 2024
REGULATED PRESS RELEASE published on 08/26/2024 at 17:39, 1 year 3 months ago Disclosure of transactions in own shares on August 19 to August 23, 2024
REGULATED PRESS RELEASE published on 08/19/2024 at 17:37, 1 year 3 months ago Disclosure of transactions in own shares on August 9 to August 16, 2024
REGULATED PRESS RELEASE published on 08/08/2024 at 18:23, 1 year 3 months ago Disclosure of transactions in own shares on August 5 to August 8, 2024
BRIEF published on 08/07/2024 at 17:40, 1 year 3 months ago Disclosure of the Number of Shares and Voting Rights as of July 31, 2024 Voting Rights Shares EURAZEO Financial Disclosure Capital Structure
REGULATED PRESS RELEASE published on 08/07/2024 at 17:35, 1 year 3 months ago Disclosure of the number of shares and the total number of voting rights as of July 31, 2024 Disclosure of total shares and voting rights by Eurazeo on July 31, 2024. Eurazeo is a leading European investment group managing diversified assets worth 35.0 billion euros Voting Rights Shares EURAZEO Investment Group Financial Disclosure
REGULATED PRESS RELEASE published on 08/05/2024 at 17:35, 1 year 3 months ago Disclosure of transactions in own shares on August 1 to August 2, 2024
Published on 12/05/2025 at 16:00, 37 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 52 minutes ago Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 1 hour 2 minutes ago XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:00, 1 hour 37 minutes ago Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 16:25, 12 minutes ago 4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 27 minutes ago Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 37 minutes ago EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 37 minutes ago EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 37 minutes ago Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 26 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 7 hours 52 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 22 hours 37 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 22 hours 52 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 22 hours 53 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution